Study Describing Cognitive Processing Speed Changes In Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)
SEX AT BIRTH: All
CONDITION: Relapsing-remitting multiple sclerosis (RRMS)
LOCATION: UH Cleveland Medical Center
The purpose of this study is to learn about changes in cognition that happen while being treated with the study drug ozanimod, taken by mouth for the treatment of RMS.
Who Can Participate
Participants diagnosed with relapsing multiple sclerosis may be eligible for this study.